Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 18, 2003

View Archived Issues

Improved MRA imaging with MS-325 in the detection of AIOD

Potential applications of ferumoxytol discussed at RSNA 2003

Adherex to acquire noncancer assets from Cadherin Biomedical

ZymoGenetics advances product candidates into clinic in 2003

Phase I study evaluates Aastrom dendritic cell-based vaccine for GI cancers

Bionomics and Brigham & Women's collaborate to identify epilepsy genes

CytoGenix ssDNA technology to be evaluated against bacterial sepsis

Orphan drug designation for DX-890 for cystic fibrosis

Pariet submitted for ZES and pathological hypersecretory conditions in Europe

GMP Companies collaborates with U. of Michigan on benzodiazepine technology

Phase I trial of topotecan TCS delayed until Q3 2004

New agreement to develop PLD-177 with Clickhaler technology

New PDE5 inhibitors reported by SK Chemicals and In2Gen team

Another series of GABA-A receptor modulators identified by Neurogen researchers

Novel 5-HT4 agonist with good safety profile and its use in GI motility disorders

Inhibitors of IL-12 production prepared and tested at Taisho

Schering AG patent covers new iNOS inhibitors and their use

CC-5013 safe and effective in hematological malignancies

Clioquinol slows rate of cognitive decline in Alzheimer's disease

Antitumor effects of CCI-779 in multiple myeloma and MCL

Efficacy and safety of lonafarnib in hematological tumors

Cytopia and Myomatrix collaborate in cardiovascular disease

COMBAT study to assess dutasteride plus tamsulosin for BPH

GTC takes equity position in Merrimack under amended MM-093 agreement

SomatoKine granted orphan drug designation for extreme insulin resistance

Investigators meeting precedes phase III Xerecept program

Xenical approved for obese adolescents

Sosei and Nippon Organon to copromote SOT-375 in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...